The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)

NCT01188824 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

801

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Cilostazol
OTHER: placebo

Sponsor

China Medical University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]